Tauns Laboratories (TSE:197A) Research & Development: 円0 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:197A Tauns Laboratories Inc TSE:197A
14 GF Score
Price 円484.00
! 6 Warning Signs
View Full Analysis

What is Tauns Laboratories Research & Development?

Tauns Laboratories TSE:197A -0.82% 14 Research & Development is 円0 Mil as of Dec. 2025. GuruFocus rates TSE:197A with a GF Score™ of 14/100. The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Tauns Laboratories's Research & Development for the three months ended in Dec. 2025 was 円0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was 円0 Mil.

Tauns Laboratories  (TSE:197A) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Tauns Laboratories Research & Development Related Terms

Tauns Laboratories Research & Development Historical Data

* Premium members only.

The historical data trend for Tauns Laboratories's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tauns Laboratories Research & Development Chart

Tauns Laboratories Annual Data
Trend Jun22 Jun23 Jun24 Jun25
Research & Development
0.00 0.00 0.00 0.00

Tauns Laboratories Quarterly Data
Jun22 Jun23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:197A
14GF Score
Tauns Laboratories Inc TSE:197A
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tauns Laboratories Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of 円0 Mil mean?
Tauns Laboratories (TSE:197A) has a Research & Development of 円0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Tauns Laboratories and its competitors.
Is Tauns Laboratories' Research & Development too high?
Tauns Laboratories' current Research & Development is 円0 Mil. Overall, Tauns Laboratories has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Tauns Laboratories' Research & Development compare to ISRG and BDX?
Tauns Laboratories' Research & Development of 円0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Tauns Laboratories and its competitors. Tauns Laboratories's current Research & Development is 円0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tauns Laboratories stock overvalued right now?
Tauns Laboratories (TSE:197A) has a current Research & Development of 円0 Mil. The current Research & Development is 円0 Mil. Tauns Laboratories' overall GF Score™ is 14/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Tauns Laboratories (TSE:197A), the current Research & Development is 円0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Tauns Laboratories Business Description

Address 761-1 Kamishima Izunokuni-shi, Shizuoka, JPN, 410-2325
Tauns Laboratories Inc is engaged in development, manufacture and sales of in vitro diagnostics and research reagents. Its product include Capilia Flu Neo, Capilia Adeno Neo, Capilia RSV Neo, Capilia hMPV, etc.
14GF Score

Get the complete analysis for TSE:197A

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円484.00
Price